Abstract:This review discusses recent advances in sequencing technologies at a single‐cell level, which are being employed for delineating the heterogeneity within different cellular subtypes in pancreatic tumors. As pancreatic tumors are highly heterogenous, further understanding of the differences within cellular subtypes will be crucial for better understanding the pathogenesis of this debilitating disease. It will be further useful to develop clinically relevant classification system for pancreatic tumors which could be used to stratify patients for personalized medicine approach using emerging targeted therapies. Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies in the world, for which the mortality is almost as high as the disease incidence and is predicted to be the second‐highest cause of cancer‐related deaths by 2030. These cancerous tumors consist of diversified gene expressions within the different cellular subpopulations that include neoplastic ductal cells, cancer‐associated fibroblasts, and immune cells, all of which collectively facilitate cellular heterogeneity in the PDAC tumor microenvironment (TME). Active intratumoral interaction within the cell populations in TME induces the proliferation of cancerous cells, accounting for tumorigenesis and rapid metastasis. Methods This review will focus on novel findings uncovering PDAC heterogeneity in different cellular subpopulations using single‐cell RNA‐sequencing (scRNA‐seq) and other single‐cell analysis technologies. It will further explore the emerging role of single‐cell technologies in assessing the role of different subpopulations of neoplastic ductal cells, cancer‐associated fibroblasts, and immune cells in PDAC progression. Results and Conclusion The application of scRNA‐seq in PDAC has started to unveil associations between disease progression and heterogeneity in pancreatic TME and could influence future PDAC treatment. Recent advances in scRNA‐seq have uncovered comprehensive analyses of heterogeneous ecosystems present within the TME. These emerging findings underpins further need for a more in‐depth understanding of intratumoral heterogeneity in the PDAC microenvironment.

Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells

The Transcriptomic Landscape of Prostate Cancer Development and Progression: an Integrative Analysis.

The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy

Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

Integrated single-cell and spatial transcriptomic analyses unravel the heterogeneity of the prostate tumor microenvironment

Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression

Spatial Intratumor Genomic Heterogeneity Within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.

Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment

Heterogeneity and complexity of the prostate epithelium: New findings from single-cell RNA sequencing studies

Single-cell transcriptomics reveals cell type diversity of human prostate

Using Single‐cell Multiple Omics Approaches to Resolve Tumor Heterogeneity

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Integration of Multiple Spatial Omics Modalities Reveals Unique Insights into Molecular Heterogeneity of Prostate Cancer

Resolution of Cellular Heterogeneity in Human Prostate Cancers: Implications for Diagnosis and Treatment

From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine

Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer

Single-cell multi-omics sequencing and its application in tumor heterogeneity.

Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues

Unveiling novel insights in prostate cancer through single-cell RNA sequencing